WE ARE THE GLOBAL LEADERS
Chemotherapy-induced hair loss is widely recognised as one of the most traumatic side effects associated with cancer treatment, and yet it is still one of the least explored. We are changing that.
Paxman has been pioneering scalp cooling technology for over a quarter of a century. Our clinically proven cold cap system has helped over 100,000 cancer patients in more than 50 countries worldwide to retain their hair during chemotherapy.
For US patients you can download the
enrollment form here.
Are you looking for patient information?
Are you looking for clinical and technical information?
The science and development behind scalp cooling.
Find out all about Paxman the family business.